Profile data is unavailable for this security.
About the company
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (induced pluripotent stem) cells. This segment manufactures research reagents used in human ES / iPS cell research, such as culture fluid, peeling liquid, frozen preservation solution, coating agents and antibody. The Clinical Testing segment clinical testing services that is required by hematopoietic stem cell transplantation and organ transplantation.
- Revenue in JPY (TTM)2.52bn
- Net income in JPY-324.61m
- Incorporated2003
- Employees99.00
- LocationReproCell Inc9F, KDX Shin-Yokohama 381 Bldg.3-8-11, Shin-Yokohama, Kohoku-kuYOKOHAMA-SHI 222-0033JapanJPN
- Phone+81 454753887
- Fax+81 454741006
- Websitehttps://reprocell.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| K Pharma Inc | 0.00 | -993.23m | 7.95bn | 17.00 | -- | 6.28 | -- | -- | -85.59 | -85.59 | 0.00 | 109.00 | 0.00 | 0.00 | -- | -- | -37.53 | -- | -38.74 | -- | -- | -- | -- | -- | 28.29 | -1,982.81 | 0.5424 | -- | -- | -- | -17.34 | -- | -- | -- |
| CellSource Co Ltd | 3.71bn | 10.66m | 8.13bn | 148.00 | 819.44 | 1.35 | 38.91 | 2.19 | 0.5003 | 0.5003 | 186.84 | 303.58 | 0.5265 | 5.91 | 11.31 | 25,077,400.00 | 0.1512 | 10.68 | 0.1613 | 11.89 | 56.24 | 64.88 | 0.2872 | 14.37 | 11.79 | 16.09 | 0.0093 | 20.88 | -14.78 | 14.87 | -95.52 | -47.76 | 8.90 | -- |
| COSMO BIO COMPANY, LIMITED | 10.51bn | 243.00m | 8.15bn | 174.00 | 31.62 | 0.8244 | 20.43 | 0.7755 | 42.64 | 42.64 | 1,842.53 | 1,635.05 | 0.891 | 6.52 | 4.02 | 60,419,540.00 | 2.08 | 5.38 | 2.41 | 6.41 | 34.20 | 36.39 | 2.34 | 5.95 | 5.52 | -- | 0.002 | 41.03 | 7.46 | 5.75 | -40.72 | 2.03 | 8.68 | 28.99 |
| Solasia Pharma KK | 326.00m | -1.80bn | 8.35bn | 23.00 | -- | 4.48 | -- | 25.60 | -8.12 | -8.12 | 1.44 | 6.91 | 0.1383 | 0.5431 | 5.67 | 14,173,910.00 | -76.18 | -64.46 | -87.38 | -80.79 | 73.93 | 59.35 | -550.92 | -401.81 | 4.27 | -77.04 | 0.0547 | -- | -48.78 | -24.75 | -74.55 | -- | -73.26 | -- |
| CellSeed Inc | 120.30m | -1.03bn | 11.16bn | 38.00 | -- | 7.98 | -- | 92.80 | -29.71 | -29.71 | 3.47 | 37.83 | 0.0562 | 1.22 | 4.75 | 3,165,816.00 | -48.11 | -45.50 | -51.99 | -49.29 | 52.72 | 57.47 | -856.11 | -478.14 | 7.05 | -- | 0.0949 | -- | 1.65 | -6.87 | -1.57 | -- | 6.39 | -- |
| Wakamoto Pharmaceutical Co Ltd | 9.29bn | 298.60m | 11.29bn | 286.00 | 37.66 | 0.93 | 15.24 | 1.21 | 8.60 | 8.60 | 267.77 | 348.39 | 0.6006 | 1.62 | 3.06 | 32,493,160.00 | 1.93 | -0.0678 | 2.22 | -0.0781 | 47.70 | 48.65 | 3.21 | -0.1246 | 2.42 | -- | 0.0082 | -- | 0.6595 | -6.53 | -40.86 | -- | 21.87 | -- |
| Stella Pharma Corp | 991.86m | -180.01m | 12.39bn | 43.00 | -- | 4.27 | -- | 12.49 | -5.29 | -5.29 | 29.15 | 85.22 | 0.1958 | 0.1084 | 2.67 | 23,066,440.00 | -3.55 | -16.41 | -3.74 | -18.19 | 87.15 | 87.03 | -18.15 | -176.16 | 12.27 | -26.44 | 0.1917 | -- | 256.62 | -- | 81.56 | -- | -21.34 | -- |
| ReproCell Inc | 2.52bn | -324.61m | 15.26bn | 99.00 | -- | 1.73 | -- | 6.06 | -3.42 | -3.42 | 26.63 | 92.82 | 0.2328 | 4.15 | 5.92 | 25,450,770.00 | -3.00 | -4.09 | -3.63 | -4.47 | 49.35 | 43.75 | -12.88 | -13.66 | 4.93 | -- | 0.00 | -- | 22.74 | 19.94 | 428.65 | -- | -6.31 | -- |
| TAIKO PHARMACEUTICAL CO LTD | 5.94bn | 853.00m | 15.29bn | 214.00 | 17.78 | 1.84 | 13.75 | 2.57 | 16.99 | 16.99 | 118.31 | 163.90 | 0.475 | 1.43 | 2.95 | 27,766,360.00 | 6.82 | -- | 8.43 | -- | 55.74 | -- | 14.36 | -- | 2.68 | -- | 0.1105 | -- | 2.81 | -- | 124.87 | -- | -- | -- |
| Immuno-Biological Laboratories Co., Ltd. | 1.03bn | 363.89m | 16.10bn | 58.00 | 44.23 | 9.13 | 59.39 | 15.60 | 39.07 | 39.07 | 110.76 | 189.25 | 0.5456 | 0.8603 | 4.81 | 17,786,030.00 | 19.25 | -4.96 | 22.46 | -5.77 | 70.35 | 62.70 | 35.27 | -11.27 | 3.96 | 2,702.08 | 0.0947 | -- | 18.71 | 10.95 | 33.40 | -- | -- | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.21bn | 17.01bn | 14.00 | -- | 6.55 | -- | -- | -62.53 | -62.53 | 0.00 | 131.71 | 0.00 | -- | -- | 0.00 | -37.50 | -57.04 | -41.74 | -62.13 | -- | -- | -- | -4,587.85 | -- | -- | 0.00 | -- | -- | -- | 4.27 | -- | -- | -- |
| Ohki Healthcare Holdings Co Ltd | 359.41bn | 2.43bn | 18.45bn | 648.00 | 7.35 | 0.5382 | 6.52 | 0.0513 | 178.43 | 178.43 | 26,346.69 | 2,435.83 | 2.26 | 9.83 | 4.34 | 554,637,400.00 | 1.53 | 1.77 | 6.23 | 7.74 | 5.31 | 5.26 | 0.677 | 0.6977 | 0.8306 | -- | 0.2686 | 14.17 | 4.42 | 4.74 | 19.41 | 2.21 | 45.68 | 6.47 |
| StemRIM Inc | 0.00 | -1.90bn | 18.55bn | 45.00 | -- | 2.70 | -- | -- | -30.56 | -30.56 | 0.00 | 109.73 | 0.00 | -- | -- | 0.00 | -24.08 | -12.71 | -24.55 | -12.88 | -- | -- | -- | -167.35 | 47.00 | -- | 0.00 | -- | -- | -- | 4.59 | -- | -22.11 | -- |
| Astena Holdings Co Ltd | 62.74bn | 2.19bn | 20.18bn | 1.42k | 9.06 | 0.7313 | 4.38 | 0.3216 | 54.22 | 54.22 | 1,555.72 | 671.41 | 0.8961 | 3.62 | 2.88 | -- | 3.11 | 0.9587 | 6.26 | 1.76 | 34.85 | 30.40 | 3.47 | 1.05 | 0.9228 | -- | 0.4519 | 114.25 | 8.19 | -0.808 | 186.60 | 1.97 | 12.61 | 2.38 |
| Fuso Pharmaceutical Industries Ltd | 62.17bn | -4.86bn | 22.45bn | 1.34k | -- | 0.5851 | -- | 0.3611 | -568.90 | -568.90 | 7,280.21 | 4,059.08 | 0.7307 | 3.25 | -- | 46,394,780.00 | -5.71 | 0.7682 | -12.18 | 1.29 | 26.39 | 26.94 | -7.82 | 1.05 | 0.8228 | 42.56 | 0.4617 | 106.29 | 9.31 | 5.25 | -338.78 | -- | 4.37 | 6.45 |
Data as of Feb 13 2026. Currency figures normalised to ReproCell Inc's reporting currency: Japanese Yen JPY
1.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 781.60k | 0.82% |
| Simplex Asset Management Co., Ltd.as of 08 Jan 2026 | 264.30k | 0.28% |
| LGT Capital Partners AG (Investment Management)as of 31 May 2025 | 0.00 | 0.00% |
Data from 30 Sep 2025 - 03 Feb 2026Source: FactSet Research Systems Inc.
